🇺🇸 FDA
Patent

US 7361665

Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

granted A61PA61P1/02A61P1/04

Quick answer

US patent 7361665 (Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 22 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18